Located within the Monash Institute of Pharmaceutical Sciences (MIPS), CDCO was established in 2003 to fill a critical gap in drug discovery—by providing translational expertise on absorption, distribution, metabolism and excretion (ADME) and pharmacokinetic (PK) properties.

CDCO has established a highly successful model for conducting interdisciplinary collaborative research within an academic environment, putting in place the systems, processes, platforms and skillsets to support user-focused research.

CDCO provides:

  • high impact, decision-quality data to enhance chemistry and biology programs
  • fully validated scientific platforms and innovative study designs
  • collaborative, flexible and responsive business models
  • an enhanced IP position and improved commercial attractiveness

CDCO brings creative insight and translational expertise to study design by running the right study at the right time. Our focus is the timely delivery of targeted data to inform and enhance drug discovery.